ArticleProtein engineering, design & selection : PEDS2014

Effects of a second-generation human anti-ErbB2 ImmunoRNase on trastuzumab-resistant tumors and cardiac cells.

Chiara D'Avino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.